We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-6.65%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$28.8B
AUM Growth
-$2.23B
Cap. Flow
+$304M
Cap. Flow %
1.06%
Top 10 Hldgs %
35.81%
Holding
611
New
169
Increased
112
Reduced
248
Closed
42

Sector Composition

Rank Sector Weight
1 Healthcare 23.32%
2 Technology 20.77%
3 Consumer Staples 14.27%
4 Consumer Discretionary 12.94%
5 Communication Services 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHC icon
1
Bausch Health
BHC
$1.66B
$1.46B 5.07%
8,176,586
+6,467,840
+379% +$1.51B
GOOG icon
2
Alphabet (Google) Class C
GOOG
$3.89T
$1.25B 4.35%
39,911,440
-262,180
-0.7% -$8.06M
PM icon
3
Philip Morris
PM
$298B
$1.14B 3.95%
14,337,492
+981,924
+7% +$80.8M
JNJ icon
4
Johnson & Johnson
JNJ
$624B
$1.08B 3.74%
11,529,743
-1,377,456
-11% -$133M
MSFT icon
5
Microsoft
MSFT
$2.83T
$1.06B 3.69%
24,002,703
-4,539,307
-16% -$204M
CSCO icon
6
Cisco
CSCO
$444B
$922M 3.2%
35,127,965
-611,945
-2% -$16.5M
BABA icon
7
Alibaba
BABA
$273B
$888M 3.08%
15,051,767
+1,473,982
+11% +$107M
AMZN icon
8
Amazon
AMZN
$2.51T
$848M 2.95%
33,129,340
-16,590,120
-33% -$419M
AAPL icon
9
Apple
AAPL
$4.72T
$846M 2.94%
30,679,920
-1,005,304
-3% -$29.5M
PG icon
10
Procter & Gamble
PG
$342B
$815M 2.83%
11,335,041
-3,198,972
-22% -$240M
UNH icon
11
UnitedHealth
UNH
$385B
$761M 2.65%
6,563,874
+278,071
+4% +$33.3M
ORCL icon
12
Oracle
ORCL
$346B
$728M 2.53%
20,144,758
-6,584,228
-25% -$253M
CHTR icon
13
Charter Communications
CHTR
$15.6B
$683M 2.37%
+3,884,492
New +$709M
KO icon
14
Coca-Cola
KO
$349B
$568M 1.97%
14,150,034
-5,873,266
-29% -$235M
QCOM icon
15
Qualcomm
QCOM
$180B
$529M 1.84%
9,836,556
-197,968
-2% -$11.8M
MMM icon
16
3M
MMM
$87.5B
$505M 1.76%
4,263,678
-216,186
-5% -$26.6M
WMT icon
17
Walmart Inc
WMT
$863B
$483M 1.68%
22,344,966
-2,581,377
-10% -$59.2M
MDT icon
18
Medtronic
MDT
$105B
$482M 1.67%
7,197,272
-348,342
-5% -$25.7M
IBM icon
19
IBM
IBM
$195B
$393M 1.37%
2,836,023
+7,199
+0.3% +$1.06M
ESRX
20
DELISTED
Express Scripts Holding Company
ESRX
$372M 1.29%
4,591,655
-6,062,839
-57% -$528M
CL icon
21
Colgate-Palmolive
CL
$72.1B
$300M 1.04%
4,722,798
-1,370,906
-22% -$89.6M
DHR icon
22
Danaher
DHR
$135B
$291M 1.01%
5,086,317
-542,642
-10% -$32.1M
CVX icon
23
Chevron
CVX
$387B
$275M 0.96%
3,485,931
-640,875
-16% -$53.9M
ACN icon
24
Accenture
ACN
$84.9B
$263M 0.91%
2,679,839
-565,852
-17% -$56.1M
ABT icon
25
Abbott
ABT
$175B
$260M 0.9%
6,469,218
-3,030,001
-32% -$143M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2015 Portfolio in Review

As of Q3 2015, Grantham, Mayo, Van Otterloo & Co (GMO) held 611 positions worth $28.8B, down 7.2% from $31B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2015 filing shows 169 new, 112 increased, 248 reduced and 42 closed positions. Its largest new stake was Charter Communications: 3,884,492 shares worth $683M. The largest sale was Express Scripts Holding Company, an estimated $528M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Staples.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2015 buy was Charter Communications: 3,884,492 shares worth $683M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Bausch Health in Q3 2015, an estimated $1.51B increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2015 reduction was Express Scripts Holding Company, cutting an estimated $528M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Check Point Software Technologies in Q3 2015, selling an estimated $155M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 36% of its $28.8B portfolio in Q3 2015.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 169 new positions and closed 42 in Q3 2015.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 7.2% quarter-over-quarter to $28.8B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2015, filed 13 Nov 2015.